A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation
about
Tegaserod for the treatment of irritable bowel syndrome and chronic constipationThe role of genetics in IBS.Abdominal bloating: pathophysiology and treatmentPractical treatments for constipation in KoreaTegaserod for constipation-predominant irritable bowel syndrome.Colonic hypersensitivity is a major determinant of the efficacy of bloating treatment in constipation-predominant irritable bowel syndrome.Review article: the treatment of functional abdominal bloating and distension.Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipationA randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation.The effect of tegaserod on symptoms and quality of life in korean women with irritable bowel syndrome with constipationNovel study designs to investigate the placebo response.Bloating and functional gastro-intestinal disorders: where are we and where are we going?Functional dyspepsia.Promotility medications--now and in the future.Guidelines on the irritable bowel syndrome: mechanisms and practical management.Review article: Linaclotide for the management of irritable bowel syndrome with constipationRole of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation.Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review.A re-randomisation design for clinical trials.Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom.Irritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic ImplicationsThe rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome.Personal view: adequate relief as a primary endpoint in irritable bowel syndrome.Randomised controlled trial of mesalazine in IBS.Drugs acting on serotonin receptors for the treatment of functional GI disorders.Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease.Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatmentMechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders.Sensory signalling effects of tegaserod in patients with irritable bowel syndrome with constipation.Use of Serotonergic Drugs in Canada for Gastrointestinal Motility Disorders: Results of a Retrospective Cohort Study.Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipationChallenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.Adequate relief in a treatment trial with IBS patients: a prospective assessment.Exploratory Study of Tegaserod for Dyspepsia in Women Receiving PPIs for HeartburnEfficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis.Prucalopride: a new drug for the treatment of chronic constipation.Asimadoline in the treatment of irritable bowel syndrome.Review article: endpoints used in functional dyspepsia drug therapy trials.Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.
P2860
Q24242922-C813E3BA-B54B-400A-BDF8-987280C12940Q24600235-53962E6D-AE2F-4AB9-B3B8-5A9F2D73BD9DQ26851622-2BA02B8D-D8C9-4AD2-9F49-26786A27A43AQ26994785-878F5815-6306-405F-81D4-21D8D33F02B9Q33436477-FB63C46D-0A86-4724-8210-0DB000B4FC5BQ33448962-4062C9BB-7ECD-4C83-8E34-596541D82C0DQ33450132-7EF460D6-03F1-4BE5-A9D9-3BB1E3051430Q33695487-CD5ECE49-90BE-47AB-95FB-52BCB32061DDQ33788020-2FAC9B02-42E9-47C2-90B9-01E9269C232FQ33890463-8B772FAC-6217-4994-890D-DF899627EACFQ33929541-CE4C06A2-F55D-4F19-A86D-FADD3D489FDDQ34366956-BD3AFAC2-508A-458B-83E7-62EEE97803BDQ34409166-912DC227-6A61-49BC-9151-CA60B30F3E26Q34548916-B1331EAE-6B52-4D9B-82FB-0B182FFF4EECQ34626602-DDBFE86A-5901-4874-925E-4B244DCC2F8AQ35008626-04589DDD-626E-4D29-9E24-260E0FA85F60Q35026383-07F2F467-3274-470F-BEF7-9F9249F47E39Q35752958-6979F450-2943-4629-BE71-09802BB8805EQ35834036-844E790D-CDA5-4F9A-A12B-397C7806E06BQ35919167-46BF4A80-204F-4DFA-AD7B-D0278C72AC98Q36207200-879F0F00-7A36-4862-84CB-4924DEB3B45AQ36407290-ED05CF17-1D25-4519-9FE3-C4F34C14F08FQ36435902-83AE39AC-1D38-447C-86C8-90C513A7C398Q36475502-F3A51A2E-2A09-47F9-9E05-7A0BB68847E0Q36478089-172DA473-A3C6-41CD-B293-4A37BB5B1E65Q36583822-0C3BD098-5018-4668-983C-EE6E3BAB7C95Q36728938-D383623B-2D9A-4F7C-8AD2-C426195635FFQ36803795-3FFFE527-9D67-4940-97ED-A9FE90520F58Q36874388-9059C37E-E0E9-4DAF-9DB3-EDFFFC43854BQ36931162-F4EB0069-52E9-4C36-B5C6-30E556F8FFDEQ36995947-0DAAF434-5E71-4CE5-818D-6B7561080766Q37045717-9D92958C-B4C8-4691-9979-3B09858491FFQ37164063-7179A912-111D-4434-B9B2-C0C5293408EEQ37253528-338BDDA3-24D1-473F-A11A-450D9BEEA318Q37262609-59DA428D-FF5E-4E74-A8EE-17EF8300D6E5Q37496549-1839CA8D-EFFD-4B34-8210-049C906A3AD3Q37578493-2063804A-85EB-4351-BECC-27CF7DACEC4AQ37784531-24F3B281-C8AC-4AB0-BF74-5AD62D013F15Q37827564-CC2D3034-FA11-4DB3-8920-69ABA20D9612Q38044067-42F496B8-C2E1-4469-80B8-FC8D8C1ED539
P2860
A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A randomised controlled trial ...... wel syndrome with constipation
@ast
A randomised controlled trial ...... wel syndrome with constipation
@en
type
label
A randomised controlled trial ...... wel syndrome with constipation
@ast
A randomised controlled trial ...... wel syndrome with constipation
@en
prefLabel
A randomised controlled trial ...... wel syndrome with constipation
@ast
A randomised controlled trial ...... wel syndrome with constipation
@en
P2093
P2860
P356
P1433
P1476
A randomised controlled trial ...... wel syndrome with constipation
@en
P2093
C Dunger-Baldauf
R Corinaldesi
S Müller-Lissner
S Schnekenbuehl
P2860
P304
P356
10.1136/GUT.2005.070789
P407
P577
2005-07-14T00:00:00Z